A share price of Evolus Inc [EOLS] is currently trading at $6.5, up 4.17%. An important factor to consider is whether the stock is rising or falling in short-term value. The EOLS shares have gain 8.51% over the last week, with a monthly amount drifted -13.45%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evolus Inc [NASDAQ: EOLS] stock has seen the most recent analyst activity on August 06, 2025, when Needham downgraded its rating to a Hold. Previously, BTIG Research started tracking the stock with Buy rating on April 17, 2025, and set its price target to $21. On January 29, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $16 on the stock. Needham started tracking the stock assigning a Buy rating and suggested a price target of $18 on June 23, 2022. Barclays upgraded its rating to a Equal Weight and raised its price target to $10 on May 12, 2022. Truist upgraded its rating to Buy for this stock on January 20, 2022, but kept the price target unchanged to $11. In a note dated May 06, 2021, Mizuho upgraded an Buy rating on this stock but restated the target price of $15.
Evolus Inc experienced fluctuations in its stock price throughout the past year between $5.71 and $17.82. Currently, Wall Street analysts expect the stock to reach $24 within the next 12 months. Evolus Inc [NASDAQ: EOLS] shares were valued at $6.5 at the most recent close of the market. An investor can expect a potential return of 269.23% based on the average EOLS price forecast.
Analyzing the EOLS fundamentals
Trailing Twelve Months sales for Evolus Inc [NASDAQ:EOLS] were 277.94M which represents 3.70% growth. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.16%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is 17.91 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-8.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.31 points at the first support level, and at 6.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.62, and for the 2nd resistance point, it is at 6.74.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Evolus Inc [NASDAQ:EOLS] is 2.27. On the other hand, the Quick Ratio is 1.86, and the Cash Ratio is 0.97. Considering the valuation of this stock, the price to sales ratio is 1.51.
Transactions by insiders
Recent insider trading involved Yamagishi-Dressler Tomoko, Chief Marketing Officer, that happened on Aug 22 ’25 when 5722.0 shares were sold. Director, Stewart Brady completed a deal on Aug 15 ’25 to buy 30000.0 shares. Meanwhile, MOATAZEDI DAVID sold 0.11 million shares on Jun 13 ’25.
